245 related articles for article (PubMed ID: 20361294)
1. Motor-dominant chronic inflammatory demyelinating polyneuropathy.
Kimura A; Sakurai T; Koumura A; Yamada M; Hayashi Y; Tanaka Y; Hozumi I; Yoshino H; Yuasa T; Inuzuka T
J Neurol; 2010 Apr; 257(4):621-9. PubMed ID: 20361294
[TBL] [Abstract][Full Text] [Related]
2. Motor chronic inflammatory demyelinating polyneuropathy (CIDP) in 17 patients: Clinical characteristics, electrophysiological study, and response to treatment.
Pegat A; Boisseau W; Maisonobe T; Debs R; Lenglet T; Psimaras D; Azoulay-Cayla A; Fournier E; Viala K
J Peripher Nerv Syst; 2020 Jun; 25(2):162-170. PubMed ID: 32364302
[TBL] [Abstract][Full Text] [Related]
3. Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy.
Kuwabara S; Isose S; Mori M; Mitsuma S; Sawai S; Beppu M; Sekiguchi Y; Misawa S
J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1054-9. PubMed ID: 25424435
[TBL] [Abstract][Full Text] [Related]
4. Clinical spectrum, treatment and outcome of children with suspected diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy.
Silwal A; Pitt M; Phadke R; Mankad K; Davison JE; Rossor A; DeVile C; Reilly MM; Manzur AY; Muntoni F; Munot P
Neuromuscul Disord; 2018 Sep; 28(9):757-765. PubMed ID: 30072201
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of intravenous immunoglobulin in CIDP.
Vucic S; Black K; Baldassari LE; Tick Chong PS; Dawson KT; Cros D
Clin Neurophysiol; 2007 Sep; 118(9):1980-4. PubMed ID: 17604689
[TBL] [Abstract][Full Text] [Related]
6. Chronic inflammatory demyelinating polyradiculoneuropathy associated with multiple sclerosis.
Sharma KR; Saadia D; Facca AG; Bhatia R; Ayyar DR; Sheremata W
J Clin Neuromuscul Dis; 2008 Jun; 9(4):385-96. PubMed ID: 18525422
[TBL] [Abstract][Full Text] [Related]
7. Nerve excitability changes after intravenous immunoglobulin infusions in multifocal motor neuropathy and chronic inflammatory demyelinating neuropathy.
Boërio D; Créange A; Hogrel JY; Guéguen A; Bertrand D; Lefaucheur JP
J Neurol Sci; 2010 May; 292(1-2):63-71. PubMed ID: 20219211
[TBL] [Abstract][Full Text] [Related]
8. Chronic inflammatory demyelinating polyneuropathy in a patient with hyperIgEaemia.
Kimura A; Yoshino H; Yuasa T
J Neurol Sci; 2005 Apr; 231(1-2):89-93. PubMed ID: 15792827
[TBL] [Abstract][Full Text] [Related]
9. A European multicentre reappraisal of distal compound muscle action potential duration in chronic inflammatory demyelinating polyneuropathy.
Rajabally YA; Lagarde J; Cassereau J; Viala K; Fournier E; Nicolas G
Eur J Neurol; 2012 Apr; 19(4):638-42. PubMed ID: 22136662
[TBL] [Abstract][Full Text] [Related]
10. Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews.
Oaklander AL; Lunn MP; Hughes RA; van Schaik IN; Frost C; Chalk CH
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010369. PubMed ID: 28084646
[TBL] [Abstract][Full Text] [Related]
11. Chronic inflammatory demyelinating polyneuropathy in patients with systemic lupus erythematosus: prognosis and outcome.
Vina ER; Fang AJ; Wallace DJ; Weisman MH
Semin Arthritis Rheum; 2005 Dec; 35(3):175-84. PubMed ID: 16325658
[TBL] [Abstract][Full Text] [Related]
12. Pure motor chronic inflammatory demyelinating polyneuropathy.
Sabatelli M; Madia F; Mignogna T; Lippi G; Quaranta L; Tonali P
J Neurol; 2001 Sep; 248(9):772-7. PubMed ID: 11596782
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of patients with refractory chronic inflammatory demyelinating polyneuropathy.
Kaplan A; Brannagan TH
Muscle Nerve; 2017 Apr; 55(4):476-482. PubMed ID: 27463215
[TBL] [Abstract][Full Text] [Related]
14. Chronic inflammatory demyelinative polyneuropathy.
Said G; Krarup C
Handb Clin Neurol; 2013; 115():403-13. PubMed ID: 23931792
[TBL] [Abstract][Full Text] [Related]
15. Chronic inflammatory demyelinating polyradiculoneuropathy in solid organ transplant recipients: a prospective study.
Echaniz-Laguna A; de Séze J; Chanson JB
J Neurol Neurosurg Psychiatry; 2012 Jul; 83(7):699-705. PubMed ID: 22577230
[TBL] [Abstract][Full Text] [Related]
16. Childhood chronic inflammatory demyelinating polyneuroradiculopathy--three cases and a review of the literature.
Riekhoff AG; Jadoul C; Mercelis R; Cras P; Ceulemans BP
Eur J Paediatr Neurol; 2012 Jul; 16(4):315-31. PubMed ID: 22225859
[TBL] [Abstract][Full Text] [Related]
17. Distribution, clinical correlates and significance of axonal loss and demyelination in chronic inflammatory demyelinating polyneuropathy.
Rajabally YA; Narasimhan M
Eur J Neurol; 2011 Feb; 18(2):293-299. PubMed ID: 20602631
[TBL] [Abstract][Full Text] [Related]
18. Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone.
Lopate G; Pestronk A; Al-Lozi M
Arch Neurol; 2005 Feb; 62(2):249-54. PubMed ID: 15710853
[TBL] [Abstract][Full Text] [Related]
19. Office immunotherapy in chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy.
Dyck PJ; Taylor BV; Davies JL; Mauermann ML; Litchy WJ; Klein CJ; Dyck PJ
Muscle Nerve; 2015 Oct; 52(4):488-97. PubMed ID: 25976871
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial.
Nobile-Orazio E; Cocito D; Jann S; Uncini A; Beghi E; Messina P; Antonini G; Fazio R; Gallia F; Schenone A; Francia A; Pareyson D; Santoro L; Tamburin S; Macchia R; Cavaletti G; Giannini F; Sabatelli M;
Lancet Neurol; 2012 Jun; 11(6):493-502. PubMed ID: 22578914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
